StonvexLoading…
StonvexStonvexStonvexCore line items from HNNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $35.54M | $29.65M | $24.02M | $29.67M |
Operating Income | $13.14M | $8.87M | $6.33M | $9.84M |
Net Income | $9.96M | $7.10M | $4.77M | $6.19M |
EPS (Diluted) | $1.27 | $0.92 | $0.63 | $0.82 |
Total Assets | $160.46M | $152.10M | $145.72M | $143.65M |
Total Liabilities | $62.72M | $60.79M | $57.97M | $57.35M |
Cash & Equivalents | $72.43M | $63.92M | $60.48M | $58.49M |
Free Cash Flow OCF − CapEx | $13.35M | $8.96M | $6.92M | $8.45M |
Shares Outstanding | 7.89M | 7.78M | 7.67M | 7.57M |